R&D Cloud powering biotech research — experiments, samples, and lab data management.
Benchling builds the leading R&D Cloud for biotechnology, used by thousands of labs to manage experiments, sample inventory, lab workflows, and bioregistries. The company was last valued at $6.1B in its November 2021 Series F and is widely viewed as an IPO candidate as biotech software consolidates.
Healthcare📍 San Francisco, USAFounded 2012
Current Valuation
$6.1B
as of 2021-Q4
UNICORN
QL Price
$6.1B
0% vs last round
QuantLogix's current estimate for Benchling, published 2026-10-07 — in line with the last disclosed round of $6.1B (2021-Q4).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$6.1B
2021-Q4
weight 0.04
How this price has held up
No round has priced for Benchling since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-07 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Benchling, 2026-10-07 (f55b215f8f1d6cf2).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookrumored
Is Benchling going public in 2026?
An IPO is rumored for 2026, with nothing filed. Benchling remains private and the date is not the company's.
What is Benchling's valuation in 2026?
Benchling is valued at $6.1B as of 2021-Q4, set by its Series F ($100M, Nov 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Benchling filed an S-1?
No public S-1 is on file for Benchling as of 10/07/2026; the IPO is rumored.
Who are Benchling's investors?
Benchling's investors include Altimeter Capital, Franklin Templeton, Tiger Global, Lone Pine Capital, Sequoia Capital, Benchmark and 1 more.
How much has Benchling raised?
Benchling has raised $412M in total, most recently a Series F of $100M in Nov 2021.
Is Benchling publicly traded — can you buy Benchling stock?
No. Benchling is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Benchling on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Sajith Wickramasekara
Founded
2012
HQ
San Francisco, USA
Employees
~800
Total Raised
$412M
Est. Revenue
$185M (2023-Q4)
Last Round
Series F — $100M (Nov 2021) · Lead: Altimeter Capital
IPO Status
rumored
Fundraising Status
Series F · $100M · 4y 11mo ago
rumoredTotal raised $412M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$100M
Nov 2021
Altimeter Capital
—
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Benchling — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-10-04. Re-checked weekly.
Talent Signal
Hiring trend
▶ Hiring steady
+2% vs 2026-08
Open roles
51
via ashby
Product-build share
29%
engineering, research, product, design
Trajectory
strengthening
balanced build + GTM — 29% builders vs 71% go-to-market/G&A — scaling both sides.
Recent senior hires: 2 senior hires (CEO, CFO).
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INRey MaliCEO · 2026-09-09
INMatt KaneCFO · 2026-09-09
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Counted from Benchling's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Sajith WickramasekaraAshu Singhal
Investors
Altimeter Capital · Franklin Templeton · Tiger Global · Lone Pine Capital · Sequoia Capital · Benchmark · Thrive Capital
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.